The Industry We Serve

Regenerative medicine deals with the process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function. There are currently over 700 clinical trials using a variety of cell sources for treatment of debilitating diseases. The size of this market is anticipated to be valued at USD 170 Billion by 2020.

In some applications, such as autologous tissue repair or cancer immunotherapy; regenerated cells would be derived from the patient's own tissue or cells, to treat degenerative disease and cancer. In other applications, stem cells would be obtained from one or a few donors and then grown in large bioreactors into therapeutically needed doses (100 million to 1 billion per dose) for injection into many unrelated patients. As part of the growth process, these cells may be differentiated to produce the type of cell required for the particular therapy.

This field holds the promise of:-

  • Immunotherapy for cancer using T cells
  • Cell regeneration and repair of tissues using mesenchymal stromal cells (MSC) and pluripotent stem cell derived tissues
  • Organ and tissue transplantations using differentiated cells